RBC Capital Starts BioMarin Pharmaceutical (BMRN) at Outperform
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $67.36 --0%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 19
Join SI Premium – FREE
RBC Capital initiates coverage on BioMarin Pharmaceutical (NASDAQ: BMRN) with an Outperform. PT $36.00.
For more ratings news on BioMarin Pharmaceutical click here and for the rating history of BioMarin Pharmaceutical click here.
Shares of BioMarin Pharmaceutical closed at $30.35 yesterday.
For more ratings news on BioMarin Pharmaceutical click here and for the rating history of BioMarin Pharmaceutical click here.
Shares of BioMarin Pharmaceutical closed at $30.35 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $88 at Piper Sandler
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- BTIG Starts Freenome Inc. (FRNM) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
